Kandi Technologies Reports Second Quarter 2024 Financial Results
August 16, 2024 07:00 ET
|
Kandi Technologies Group, Inc.
Strong Financial Position with ~$220 million cash and cash equivalentsReturned Capital to Shareholders via Active Share Repurchase ProgramIntroduced Officially Licensed NFL Team Golf Carts Exclusively...
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 16, 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
August 16, 2024 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
World Health Organization (WHO) has declared spread of mpox in multiple African countries a public health emergency of international concern (PHEIC) 1 Tonix’s live virus vaccine candidate, TNX-801,...
ChampionX Declares Quarterly Dividend
August 16, 2024 07:00 ET
|
ChampionX Corporation
THE WOODLANDS, Texas, Aug. 16, 2024 (GLOBE NEWSWIRE) -- ChampionX Corporation (Nasdaq: CHX) announced today its Board of Directors has declared a regular quarterly dividend of $0.095 per share on...
Pfizer und BioNTech geben Update zu mRNA-basiertem Kombinationsimpfstoffprogramm gegen Grippe und COVID-19 bei Personen im Alter von 18 bis 64 Jahren bekannt
August 16, 2024 06:45 ET
|
BioNTech SE
Pfizers und BioNTechs Kombinationsimpfstoffkandidat gegen Grippe und COVID-19 hat in einer Phase-3-Studie eines ihrer beiden primären Ziele zur Immunogenität erreichtDie Studie erreichte eines ihrer...
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
August 16, 2024 06:45 ET
|
BioNTech SE
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectivesThe trial did not meet one of its primary...
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
August 16, 2024 06:30 ET
|
Liquidia Corporation
Liquidia Corporation (NASDAQ: LQDA) will present nine encore thematic posters at the 2024 Pulmonary Hypertension Association (PHA) International Conference
KANZHUN LIMITED to Report Second Quarter 2024 Results on August 28, 2024
August 16, 2024 06:15 ET
|
Kanzhun Limited
BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it will...
Jiayin Group Inc. Announces Cash Dividends
August 16, 2024 06:00 ET
|
Jiayin Group Inc.
SHANGHAI, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that its board of directors approved...
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024 06:00 ET
|
Immuron Limited
Highlights: $3.5 (USD $2.3) million funding for NMRC and WRAIR approved by the U.S. Department of Defense to advance the development of Travelan. MELBOURNE, Australia, Aug. 16,...